Current Opinion in Pharmacology

1

Role of TRPV1 in inflammation-induced airway hypersensitivity

Lu-Yuan Lee, Qihai Gu

Journal:

Year:

2009

Language:

english

File:

PDF, 1.93 MB

english, 2009

2

Inhaled muscarinic antagonists for COPD—does an anti-inflammatory mechanism really play a role?

Michael Trevethick, Nicholas Clarke, Matthew Strawbridge, Michael Yeadon

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 299 KB

english, 2009

3

Purinergic receptors in airway epithelia

Eduardo R Lazarowski, Richard C Boucher

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 315 KB

english, 2009

4

Serotonin and pulmonary hypertension—from bench to bedside?

Margaret R MacLean, Yvonne Dempsie

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 340 KB

english, 2009

5

Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem

Jeremy PT Ward, Ivan F McMurtry

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 759 KB

english, 2009

6

TGF-β and BMPR-II pharmacology—implications for pulmonary vascular diseases

Paul D Upton, Nicholas W Morrell

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 481 KB

english, 2009

7

The role of animal models in the pharmacological evaluation of emerging anti-inflammatory agents for the treatment of COPD

J Craig Fox, Mary F Fitzgerald

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 657 KB

english, 2009

8

Cell therapy approaches for lung diseases: current status

Viranuj Sueblinvong, Daniel J Weiss

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 156 KB

english, 2009

9

How will genetic approaches assist in the management of respiratory diseases?

Ian P Hall

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 276 KB

english, 2009

10

Neuro-exocytosis: botulinum toxins as inhibitory probes and versatile therapeutics

J Oliver Dolly, Gary W Lawrence, Jianghui Meng, Jiafu Wang, Saak V Ovsepian

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 2.50 MB

english, 2009

11

Nicotinic acetylcholine receptors at atomic resolution

Victor Tsetlin, Ferdinand Hucho

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 1.11 MB

english, 2009

12

Mammalian neuromuscular junctions: modern tools to monitor synaptic form and function

Richard R Ribchester

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 3.07 MB

english, 2009

13

Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models

Luc Dupuis, Jean-Philippe Loeffler

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 512 KB

english, 2009

14

Ins and outs of cardiac voltage-gated potassium channels

Olaf Pongs

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 258 KB

english, 2009

15

Novel pharmacological approaches to airway and pulmonary vascular disease

Clive Page, Mandy MacLean

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 87 KB

english, 2009

16

Cholinesterases and the basal lamina at vertebrate neuromuscular junctions

Jean Massoulié, Charles B Millard

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 2.02 MB

english, 2009

17

Autoimmune disorders of the neuromuscular junction

Bethan Lang, Angela Vincent

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 261 KB

english, 2009

18

Editorial Board

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 49 KB

english, 2009

19

Forthcoming Articles

Journal:

Current Opinion in Pharmacology

Year:

2009

Language:

english

File:

PDF, 90 KB

english, 2009

Volume 9; Issue 3

Role of TRPV1 in inflammation-induced airway hypersensitivity

Inhaled muscarinic antagonists for COPD—does an anti-inflammatory mechanism really play a role?

Purinergic receptors in airway epithelia

Serotonin and pulmonary hypertension—from bench to bedside?

Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem

TGF-β and BMPR-II pharmacology—implications for pulmonary vascular diseases

The role of animal models in the pharmacological evaluation of emerging anti-inflammatory agents for the treatment of COPD

Cell therapy approaches for lung diseases: current status

How will genetic approaches assist in the management of respiratory diseases?

Neuro-exocytosis: botulinum toxins as inhibitory probes and versatile therapeutics

Nicotinic acetylcholine receptors at atomic resolution

Mammalian neuromuscular junctions: modern tools to monitor synaptic form and function

Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models

Ins and outs of cardiac voltage-gated potassium channels

Novel pharmacological approaches to airway and pulmonary vascular disease

Cholinesterases and the basal lamina at vertebrate neuromuscular junctions

Autoimmune disorders of the neuromuscular junction

Editorial Board

Contents

Forthcoming Articles